Company / Current Assets
Q32 Bio Inc. Current Assets History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$55.0M
FY2025
5-year range
$55.0M / $191.9M
FY2021-FY2025
Trend
-32.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has declined for 6 consecutive years, from $267M in FY2019 to $55M in FY2025.
Based on SEC 10-K filings.
$55M in FY2025 with a 5-year CAGR of -24.2%.
Declined from $84M to $55M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -32.8%
- 5-Year CAGR
- -24.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- Q32 Bio Inc.'s current assets has declined for 6 consecutive years.
- 5-year CAGR of -24.2%, indicating a declining trend.
- In FY2025, current assets decreased 32.8% year-over-year.
- Peak current assets was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -2.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $55.0M | -32.8% |
| FY2024 | $81.9M | -2.4% |
| FY2023 | $83.9M | -53.6% |
| FY2022 | $181.0M | -5.7% |
| FY2021 | $191.9M | -12.6% |
| FY2020 | $219.6M | -17.6% |
| FY2019 | $266.6M | +20.3% |
| FY2018 | $221.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026